0897.HK

Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or less in the six months through September, the first half of its fiscal year, from the HK$23.7 million a year earlier.

The company said its retail business was hit by weak consumer sentiment during the reporting period, resulting in a 7% drop in revenue and a corresponding decline in gross profit. Meanwhile, its net gain from property disposals also fell significantly, and a decrease in fair value gains of its investment properties further weighed on its profits. Those negative factors were partially offset by lower administrative expenses and financing costs, it added.

Wai Yuen Tong’s stock opened flat on Tuesday and closed at HK$0.45 by the midday break, with no change. The stock is up about 80% year-to-date.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Goodbaby makes strollers

Investors left crying as U.S. tariffs hit Goodbaby

The world’s leading producer of baby strollers and car seats is getting socked by a double whammy of U.S. tariffs and China’s baby bust Key Takeaways: Goodbaby reported its revenue…
Seeking a profile boost, Boxihe pivots to Hong Kong IPO

Seeking a profile boost, Boxihe pivots to Hong Kong IPO

The maker of high-performance outdoor clothing is betting on rising demand for its Pelliot apparel range in China’s still relatively untapped market   Key Takeaways: The company’s pre-IPO backers include Tencent…
Damai sells concert tickets

Damai rides China’s offline leisure boom to bumper profits

The company’s dominance in live entertainment ticketing and IP franchises has turbocharged its revenue, despite persistent consumer complaints and monopolistic behavior Key Takeaways: Damai’s profit rose around 50% in the…